Parexel Exec On How CROs Should Prepare For Biosimilar Pathway, AI-Led Changes

 
• By Vibha Ravi
  
Parexel's India Head Sanjay Vyas Talks About Biosimilar Pathways, RWE and AI
Parexel's India Head Sanjay Vyas Talks About Biosimilar Pathways, RWE and AI (s STE StephanieEWENS Stephan/Stephanie Ewens Photography)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Interviews

More from Review Pathways